POAGX Mutual Fund Forecast & Price Targets

Compare

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

POAGX Analyst Rating

Strong Buy

160 Buy

28 Hold

2 Sell

Based on the consensus analyst ratings on 190 stocks held in POAGX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

POAGX Analyst Price Target

Average Price Target

$57.49

Based on 190 Wall Street analysts offering 12 month price targets to PRIMECAP Odyssey Aggressive Growth Fund holdings in the last 3 months. The average price target is $57.49 with a high forecast of $74.33 and a low forecast of $44.46. The average price target represents a 40.18% change from the last price of $41.01.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"39":"$39","48":"$48","57":"$57","66":"$66","75":"$75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":74.329,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$74.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":57.488,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$57.49</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":44.459,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$44.46</span>\n  </div></div>","useHTML":true}}],"tickPositions":[39,48,57,66,75],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Jan<br/>2025","12":"Apr<br/>2025","25":"Apr<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,40.58,43.17607692307692,45.77215384615384,48.36823076923076,50.964307692307685,53.560384615384606,56.156461538461535,58.75253846153846,61.34861538461538,63.9446923076923,66.54076923076923,69.13684615384615,71.73292307692307,{"y":74.329,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,40.58,41.88061538461538,43.181230769230766,44.48184615384615,45.78246153846154,47.08307692307692,48.38369230769231,49.68430769230769,50.984923076923074,52.285538461538465,53.58615384615385,54.88676923076923,56.187384615384616,{"y":57.488,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,40.58,40.87838461538461,41.17676923076923,41.475153846153844,41.773538461538465,42.07192307692308,42.37030769230769,42.66869230769231,42.967076923076924,43.26546153846154,43.56384615384616,43.86223076923077,44.16061538461539,{"y":44.459,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":44.96,"date":1711929600000,"info":"<div>Price: <b>$45<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":43.13,"date":1714521600000,"info":"<div>Price: <b>$43<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":44.87,"date":1717372800000,"info":"<div>Price: <b>$45<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":45.37,"date":1719792000000,"info":"<div>Price: <b>$45<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":43.75,"date":1722470400000,"info":"<div>Price: <b>$44<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":44.1,"date":1725321600000,"info":"<div>Price: <b>$44<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":46.57,"date":1727740800000,"info":"<div>Price: <b>$47<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":46.6,"date":1730419200000,"info":"<div>Price: <b>$47<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":49.98,"date":1733097600000,"info":"<div>Price: <b>$50<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":44.29,"date":1735776000000,"info":"<div>Price: <b>$44<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":45.57,"date":1738540800000,"info":"<div>Price: <b>$46<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":43.32,"date":1740960000000,"info":"<div>Price: <b>$43<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.58,"date":1743465600000,"info":"<div>Price: <b>$41<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$74.33

Average Price Target$57.49

Lowest Price Target$44.46

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

POAGX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

NKTR

Nektar Therapeutics

6 Buy

1 Hold

1 Sell

Moderate Buy

$4.92

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ALLO

Allogene Therapeutics

11 Buy

1 Hold

0 Sell

Strong Buy

$8.50

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ZNTL

Zentalis Pharmaceuticals Inc

5 Buy

6 Hold

0 Sell

Moderate Buy

$6.27

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ARAY

Accuray Incorporated

4 Buy

0 Hold

0 Sell

Strong Buy

$6.13

xxxxxxxxxxxxxxxxxxxxxxxxxxx

INDI

Indie Semiconductor, Inc.

4 Buy

0 Hold

0 Sell

Strong Buy

$7.33

POAGX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

HTZ

Hertz Global Holdings Inc

0 Buy

2 Hold

2 Sell

Moderate Sell

$2.93

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GRAL

Grail Inc

1 Buy

2 Hold

0 Sell

Moderate Buy

$26.00

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GLPG

Galapagos NV

0 Buy

2 Hold

2 Sell

Moderate Sell

$25.75

xxxxxxxxxxxxxxxxxxxxxxxxxxx

EBAY

Ebay Inc

8 Buy

16 Hold

2 Sell

Hold

$66.58

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TTWO

Take-Two Interactive

16 Buy

1 Hold

0 Sell

Strong Buy

$223.53

POAGX Mutual Fund FAQ

What is POAGX’s average 12-month price target, according to analysts?

Based on analyst ratings, PRIMECAP Odyssey Aggressive Growth Fund’s 12-month average price target is 57.49.

What is POAGX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for POAGX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is POAGX a Buy, Sell or Hold?

PRIMECAP Odyssey Aggressive Growth Fund has a consensus rating of Strong Buy which is based on 160 buy ratings, 28 hold ratings and 2 sell ratings.

What is PRIMECAP Odyssey Aggressive Growth Fund’s price target?

The average price target for PRIMECAP Odyssey Aggressive Growth Fund is 57.49. This is based on 190 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $74.33 ,the lowest forecast is $44.46. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about PRIMECAP Odyssey Aggressive Growth Fund?

PRIMECAP Odyssey Aggressive Growth Fund’s analyst rating consensus is a Strong Buy. This is based on the ratings of 190 Wall Streets Analysts.

How can I buy shares of POAGX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing